Vivakor announced multiple financing actions, including a two-tranche notes financing providing $12.0 million in gross proceeds (reflecting $15.0 million in principal with a 20% original issue discount) under a Securities Purchase Agreement with institutional investors. The company also established a standby equity purchase agreement for up to $100 million over 36 months, offering flexible, on-demand equity draws subject to pricing and volume limits. On July 15, 2026, Vivakor and investors amended the SPA, Notes and SEPA to maintain a $0.37 floor price following a 1-for-20 reverse stock split, facilitating the second closing and continued capital access.
Agreement 1: Vivakor Secures $12 Million Note Financing With Institutional Investors; $15 Million Principal With 20% OID
- Agreement type: Securities Purchase Agreement for $15M principal notes (20% OID)
- Counterparty: Institutional investors
- Signed / Effective: May 08 2026 / same
- Duration / Termination: N/A
- Reason: Strengthen liquidity and fund operations
Agreement 2: Vivakor Establishes Up To $100 Million Equity Line Under Standby Purchase Agreement
- Agreement type: Standby equity purchase agreement (equity line) up to $100M
- Counterparty: Institutional investor
- Signed / Effective: May 07 2026 / same
- Duration / Termination: 36 months
- Reason: Flexible equity funding to support operations
Agreement 3: Vivakor Amends Financing Documents to Maintain $0.37 Floor and Enable Second Closing
- Agreement type: Amendment No. 1 to SPA, Notes and SEPA
- Counterparty: Institutional investors
- Signed / Effective: Jul 15 2026 / same
- Duration / Termination: N/A
- Reason: Secure second closing and maintain post-split floor price
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.